ACIU Historical Cash Flow
| ACIU Stock | USD 1.98 0.14 6.60% |
Analysis of AC Immune cash flow over time is an excellent tool to project AC Immune future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 68.5 M or Change In Working Capital of 112.9 M as it is a great indicator of AC Immune ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining AC Immune latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AC Immune is a good buy for the upcoming year.
ACIU |
About ACIU Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ACIU balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ACIU's non-liquid assets can be easily converted into cash.
AC Immune Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by AC Immune to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of AC Immune operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from AC Immune's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into AC Immune current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.At this time, AC Immune's Free Cash Flow is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 112.9 M in 2025, whereas Stock Based Compensation is likely to drop slightly above 2.8 M in 2025.
AC Immune cash flow statement Correlations
Click cells to compare fundamentals
AC Immune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AC Immune cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 69K | (100K) | 0.0 | (8K) | (7.2K) | (6.8K) | |
| Change In Cash | (32.7M) | (78.7M) | (50.6M) | 46.9M | (42.2M) | (40.1M) | |
| Stock Based Compensation | 4.1M | 4.1M | 3.3M | 4.4M | 5.5M | 2.8M | |
| Free Cash Flow | (61.2M) | (68.3M) | (74.8M) | (61.2M) | 65.3M | 68.5M | |
| Change In Working Capital | (4.6M) | 6.8M | (8.4M) | (15.2M) | 107.5M | 112.9M | |
| Begin Period Cash Flow | 193.6M | 160.9M | 82.2M | 31.6M | 78.5M | 100.1M | |
| Total Cashflows From Investing Activities | (66.9M) | 28.3M | (53.7M) | 23.8M | 21.4M | 22.5M | |
| Other Cashflows From Financing Activities | (371K) | (6K) | (776K) | 65.6M | (548K) | (520.6K) | |
| Depreciation | 2.0M | 2.4M | 2.4M | 2.2M | 2.2M | 1.4M | |
| Other Non Cash Items | 551K | (6.2M) | (72K) | 2.4M | 1.6M | 1.7M | |
| Capital Expenditures | 1.7M | 2.6M | 1.2M | 801K | 576K | 547.2K | |
| Total Cash From Operating Activities | (59.5M) | (65.7M) | (73.6M) | (60.4M) | 65.8M | 69.1M | |
| Change To Account Receivables | (25K) | (99K) | 36K | (14.8M) | 13.6M | 14.2M | |
| Change To Operating Activities | 3.4M | (2.6M) | 6.6M | (7.3M) | (6.5M) | (6.2M) | |
| Net Income | (61.9M) | (73.0M) | (70.8M) | (54.2M) | (50.9M) | (48.4M) | |
| Total Cash From Financing Activities | (803K) | 40.7M | (1.3M) | 43.3M | (1.1M) | (1.1M) | |
| End Period Cash Flow | 160.9M | 82.2M | 31.6M | 78.5M | 36.3M | 34.5M | |
| Other Cashflows From Investing Activities | 30.0M | (51.0M) | 25.0M | 66.4M | (104.7M) | (99.5M) | |
| Change To Netincome | 2.4M | 5.0M | (1.9M) | 3.3M | 3.7M | 3.9M | |
| Change To Liabilities | 2.3M | (2.0M) | 341K | (1.2M) | (1.4M) | (1.5M) | |
| Investments | 30M | (53.7M) | 23.8M | 65.6M | (105.3M) | (100.0M) | |
| Net Borrowings | 50.1M | (946K) | 23.0M | (569K) | (654.4K) | (621.6K) | |
| Issuance Of Capital Stock | 100K | 16.7M | 4.3M | 43.8M | 111K | 105.5K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.